Interview: Michael Dembinksi – Chief Advisor, British Polish Chamber of Commerce, Poland

Michael Dembinski, chief advisor of the British Polish Chamber of Commerce, discusses the important role of the chamber in driving forward Polish clinical trials and the challenges in unlocking Poland’s R&D potential. He also highlights the possible impact of Brexit and looks at the similarities and differences of business culture between the two nations. As the chief advisor, could you introduce to our international readers the British Polish Chamber of Commerce?
"Poland has the bright minds on hand to kick start larger investments, but it also needs institutional support and must tackle legislative areas head-on to simplify processes and attract further investment."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report